胃型宫颈内膜腺癌的诊断与管理:一例病例报告及文献综述
本文报告一例胃型宫颈内膜腺癌(GEA),并综述其组织病理学特征、2020年世界卫生组织(WHO)分类、KRAS、ARID1A和PIK3CA基因突变、临床结局异质性及治疗策略,包括手术、放疗、化疗及靶向和免疫治疗等新兴方法。
要点
- 胃型宫颈内膜腺癌(GEA)是宫颈癌罕见亚型,2020年WHO分类才将其列为独立亚型。
- GEA具有特征性形态学表现,临床实践中易误诊或分类错误。
- KRAS、ARID1A和PIK3CA突变在GEA发生发展中起重要作用。
核心结论
- 本文综述GEA的分类、遗传学、结局和治疗策略,强调其诊断挑战和精准医学前景。
研究设计与样本
- 病例报告及文献综述,报告一例GEA并综合现有知识。
主要发现
- GEA具有独特组织病理学特征,KRAS、ARID1A和PIK3CA突变参与其发生发展。
- GEA患者临床结局异质,与诊断分期、组织学分级和遗传学改变等因素有关。
- 治疗策略包括手术、放疗和化疗,靶向治疗和免疫治疗等新兴方法正在探索中。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Gastric-type endocervical adenocarcinoma (GEA), a rare subtype of cervical cancer, has garnered increasing attention recently for its distinctive histopathological features, unique classification, genetic characteristics, and variable clinical outcomes compared to squamous cell and adenocarcinoma subtypes. Historically, GEA has evolved from a poorly understood entity to a distinct subtype of cervical adenocarcinoma, only recently recognized in the 2020 World Health Organization (WHO) classification. Accordingly, characteristic morphological features define GEA, shedding light on the diagnostic challenges and potential misclassification that can occur in clinical practice. Genetic alterations, including KRAS, ARID1A, and PIK3CA mutations, play a pivotal role in the development and progression of GEA. This article reviews a case of GEA and aims to provide a contemporary overview of the genetic mutations and molecular pathways implicated in GEA pathogenesis, highlighting potential therapeutic targets and the prospects of precision medicine in its management. Patients with GEA have variable clinical outcomes, with some exhibiting aggressive behavior while others follow a more indolent course. This review examines the factors contributing to this heterogeneity, including stage at diagnosis, histological grade, and genetic alterations, and their implications for patient prognoses. Treatment strategies for GEA remain a topic of debate and research. Here, we summarize the current therapeutic options, including surgery, radiation therapy, and chemotherapy, while also exploring emerging approaches, such as targeted therapies and immunotherapy. This article provides a comprehensive overview of GEA, synthesizing current knowledge from historical perspectives to contemporary insights, focusing on its classification, genetics, outcomes, and therapeutic strategies.
引用
- Chalif J, Kistenfeger Q, Fulton J, et al. Diagnosis and management of gastric-type endocervical adenocarcinoma: A case report and review of the literature. Gynecol Oncol. 2024. PMID: 38428332. doi:10.1016/j.ygyno.2024.02.024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。